Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS.
Blood Adv
; 7(13): 3075-3079, 2023 Jul 11.
Article
in English
| MEDLINE | ID: covidwho-2260747
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Hematopoietic Stem Cell Transplantation
/
COVID-19
Type of study:
Experimental Studies
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Blood Adv
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS